The use of contact lenses as biosensors

Optometry and Vision Science

Volumn 93, Issue 4, 2016, Pages 419-425

  Phan, Chau Minh ^a   Subbaraman, Lakshman ^a   Jones, Lyndon W ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Biosensor; Contact lens; Diabetes; Glaucoma; Glucose; Tear biomarkers

Indexed keywords

MULTILAYER FILMS;

CONTACT LENS SENSORS; INTRA OCULAR PRESSURE; TEAR FILMS;

CONTACT LENSES;

GLUCOSE;

CHEMISTRY; CONTACT LENS; DEVICES; DIABETES COMPLICATIONS; GENETIC PROCEDURES; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; LACRIMAL FLUID; PHYSIOLOGIC MONITORING; PHYSIOLOGY;

BIOSENSING TECHNIQUES; CONTACT LENSES; DIABETES COMPLICATIONS; GLAUCOMA; GLUCOSE; HUMANS; INTRAOCULAR PRESSURE; MONITORING, PHYSIOLOGIC; TEARS;

EID: 84949908764     PISSN: 10405488     EISSN: 15389235     Source Type: Journal    
DOI: 10.1097/OPX.0000000000000763     Document Type: Review

References (70)

1. Jalbert I. Diet, nutraceuticals and the tear film. Exp Eye Res 2013; 117:138-46.
2. Holly FJ, Lemp MA. Tear physiology and dry eyes. Surv Ophthalmol 1977;22:69-87.
3. Tiffany JM. The normal tear film. Dev Ophthalmol 2008;41:1-20.
4. Snyder C, Fullard RJ. Clinical profiles of non dry eye patients and correlations with tear protein levels. Int Ophthalmol 1991;15: 383-9.
5. Tiffany JM. Tears in health and disease. Eye (Lond) 2003;17:923-6.
6. Sen DK, Sarin GS. Tear glucose levels in normal people and in diabetic patients. Br J Ophthalmol 1980;64:693-5.
7. von Thun Und Hohenstein-Blaul N, Funke S, Grus FH. Tears as a source of biomarkers for ocular and systemic diseases. Exp Eye Res 2013;117:126-37.
8. Badugu R, Lakowicz JR, Geddes CD. A glucose-sensing contact lens: from bench top to patient. Curr Opin Biotechnol 2005;16:100-7.
9. Zhou L, Beuerman RW, Chan CM, Zhao SZ, Li XR, Yang H, Tong L, Liu S, Stern ME, Tan D. Identification of tear fluid bio-markers in dry eye syndrome using iTRAQ quantitative proteomics. J Proteome Res 2009;8:4889-905.
10. Tong L, Zhou L, Beuerman RW, Zhao SZ, Li XR. Association of tear proteins with Meibomian gland disease and dry eye symptoms. Br J Ophthalmol 2011;95:848-52.
11. Leonardi M, Leuenberger P, Bertrand D, Bertsch A, Renaud P. First steps toward noninvasive intraocular pressure monitoring with a sensing contact lens. Invest Ophthalmol Vis Sci 2004;45:3113-7.
12. Lebrecht A, Boehm D, Schmidt M, Koelbl H, Schwirz RL, Grus FH. Diagnosis of breast cancer by tear proteomic pattern. Cancer Genomics Proteomics 2009;6:177-82.
13. Boehm D, Lebrecht A, Keller K, Schwirz R, Schmidt M, Grus F, Kolbl H. Proteome using protein chips in serum and tear fluid: identification of biomarkers for early detection of breast cancer. Geburtshilfe Und Frauenheilkunde 2009;69:736.
14. You J, Cozzi P, Walsh B, Willcox M, Kearsley J, Russell P, Li Y. Innovative biomarkers for prostate cancer early diagnosis and progression. Crit Rev Oncol Hematol 2010;73:10-22.
15. You J, Willcox MD, Madigan MC, Wasinger V, Schiller B, Walsh BJ, Graham PH, Kearsley JH, Li Y. Tear fluid protein bio-markers. Adv Clin Chem 2013;62:151-96.
16. Hagan S, Tomlinson A. Tear fluid biomarker profiling: a review of multiplex bead analysis. Ocul Surf 2013;11:219-35.
17. Huang ES, O'Grady M, Basu A, Winn A, John P, Lee J, Meltzer D, Kollman C, Laffel L, Tamborlane W, Weinzimer S, Wysocki T. The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetes Care 2010;33:1269-74.
18. McQueen RB, Ellis SL, Campbell JD, Nair KV, Sullivan PW. Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes. Cost Eff Resour Alloc 2011;9:13.
19. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services: National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; 2014. Available at: http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf. Accessed July 28, 2015.
20. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
21. Klonoff DC. Noninvasive blood glucose monitoring. Diabetes Care 1997;20:433-7.
22. Badugu R, Lakowicz JR, Geddes CD. Noninvasive continuous monitoring of physiological glucose using a monosaccharide-sensing contact lens. Anal Chem 2004;76:610-8.
23. Alexeev VL, Das S, Finegold DN, Asher SA. Photonic crystal glucose-sensing material for noninvasive monitoring of glucose in tear fluid. Clin Chem 2004;50:2353-60.
24. Liao Y-T, Yao H, Lingley A, Parviz B, Otis BP. A 3-uW CMOS glucose sensor for wireless contact-lens tear glucose monitoring. IEEE JSSC 2012;47:335-44.
25. Otis B, Liao YT, Amirparviz B, Yao H. Wireless powered contact lens with biosensor 2013 US Patent 8608310 B2.
26. Lewis JG. Tear-test for glucose. Br Med J 1957;1:585.
27. Cummins BM, Garza JT, Coté GL. Optimization of a concanavalin AYbased glucose sensor using fluorescence anisotropy. Anal Chem 2013;85:5397-404.
28. Müller A. Ocular sensor for the detection of an analyte in eye water 2013 US Patent 8452361 B2.
29. Clark LC Jr., Lyons C. Electrode systems for continuous monitoring in cardiovascular surgery. Ann N Y Acad Sci 1962;102:29-45.
30. Miyashita M, Ito N, Ikeda S, Murayama T, Oguma K, Kimura J. Development of urine glucose meter based on micro-planer am-perometric biosensor and its clinical application for self-monitoring of urine glucose. Biosens Bioelectron 2009;24:1336-40.
31. Koudelka M, Gernet S, De Rooij NF. Planar amperometric enzyme-based glucose microelectrode. Sensor Actuator B 1989;18:157-65.
32. Park S, Boo H, Chung TD. Electrochemical non-enzymatic glucose sensors. Anal Chim Acta 2006;556:46-57.
33. Liu M, Liu R, Chen W. Graphene wrapped Cu2O nanocubes: non-enzymatic electrochemical sensors for the detection of glucose and hydrogen peroxide with enhanced stability. Biosens Bioelectron 2013;45:206-12.
34. Feng D, Wang F, Chen Z. Electrochemical glucose sensor based on one-step construction of gold nanoparticleYchitosan composite film. Sens Actuat B-Chem 2009;138:539-44.
35. Vaddiraju S, Burgess DJ, Tomazos I, Jain FC, Papadimitrakopoulos F. Technologies for continuous glucose monitoring: current problems and future promises. J Diabetes Sci Technol 2010;4:1540-62.
36. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001;24:1858-62.
37. Yki-Järvinen H, Dressler A, Ziemen M. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group. Diabetes Care 2000;23:1130-6.
38. Zhang J, Hodge W, Hutnick C, Wang X. Noninvasive diagnostic devices for diabetes through measuring tear glucose. J Diabetes Sci Technol 2011;5:166-72.
39. Dumbleton K, Woods CA, Jones LW, Fonn D. The impact of contemporary contact lenses on contact lens discontinuation. Eye Contact Lens 2013;39:93-9.
40. Dumbleton K. Adverse events with silicone hydrogel continuous wear. Cont Lens Anterior Eye 2002;25:137-46.
41. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014;121:2081-90.
42. Friedman DS, Wolfs RC, O'Colmain BJ, Klein BE, Taylor HR, West S, Leske MC, Mitchell P, Congdon N, Kempen J. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol 2004;122:532-8.
43. Wilensky JT. Diurnal variations in intraocular pressure. Trans Am Ophthalmol Soc 1991;89:757-90.
44. Jorge J, Ramoa-Marques R, Lourenço A, Silva S, Nascimento S, Queirós A, Gonzalez-Méijome JM. IOP variations in the sitting and supine positions. J Glaucoma 2010;19:609-12.
45. Lee TE, Yoo C, Kim YY. Effects of different sleeping postures on intraocular pressure and ocular perfusion pressure in healthy young subjects. Ophthalmology 2013;120:1565-70.
46. Leonardi M, Pitchon EM, Bertsch A, Renaud P, Mermoud A. Wireless contact lens sensor for intraocular pressure monitoring: assessment on enucleated pig eyes. Acta Ophthalmol 2009;87:433-7.
47. Faschinger C, Mossböck G. Continuous 24 h monitoring of changes in intraocular pressure with the wireless contact lens sensor Trig-gerfish. First results in patients. Ophthalmologe 2010;107:918-22.
48. Pajic B, Pajic-Eggspuchler B, Haefliger I. Continuous IOP fluctuation recording in normal tension glaucoma patients. Curr Eye Res 2011;36:1129-38.
49. Mansouri K, Shaarawy T. Continuous intraocular pressure monitoring with a wireless ocular telemetry sensor: initial clinical experience in patients with open angle glaucoma. Br J Ophthalmol 2011;95:627-9.
50. Twa MD, Roberts CJ, Karol HJ, Mahmoud AM, Weber PA, Small RH. Evaluation of a contact lensYembedded sensor for intraocular pressure measurement. J Glaucoma 2010;19:382-90.
51. Faschinger C, Mossböck G. Validity of the results of a contact lens sensor? JAMA Ophthalmol 2013;131:696-7.
52. Sunaric-Megevand G, Leuenberger P, PreuQner PR. Assessment of the Triggerfish contact lens sensor for measurement of intraocular pressure variations. Acta Ophthalmol 2014;92:e414-5.
53. Subbaraman LN, Glasier MA, Senchyna M, Sheardown H, Jones L. Kinetics of in vitro lysozyme deposition on silicone hydrogel, PMMA, and FDA groups I, II, and IV contact lens materials. Curr Eye Res 2006;31:787-96.
54. Bacon AS, Astin C, Dart JK. Silicone rubber contact lenses for the compromised cornea. Cornea 1994;13:422-8.
55. National Institute for Health and Care Excellence, 2014. The SENSIMED Triggerfish contact lens sensor for continuous 24-hour recording of ocular dimensional changes in people with or at risk of developing glaucoma. Available at: http://www.nice.org.uk/advice/mib14. Accessed December 7, 2014.
56. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262-7.
57. Skyler JS, Oddo C. Diabetes trends in the USA. Diabetes Metab Res Rev 2002;18(Suppl. 3):S21-6.
58. McArthur SL, McLean KM, St John HA, Griesser HJ. XPS and surface-MALDI-MS characterisation of worn HEMA-based contact lenses. Biomaterials 2001;22:3295-304.
59. Alberghina D, Giannetto C, Vazzana I, Ferrantelli V, Piccione G. Reference intervals for total protein concentration, serum protein fractions, and albumin/globulin ratios in clinically healthy dairy cows. J Vet Diagn Invest 2011;23:111-4.
60. McGill JI, Liakos GM, Goulding N, Seal DV. Normal tear protein profiles and age-related changes. Br J Ophthalmol 1984;68:316-20.
61. Ananthi S, Santhosh RS, Nila MV, Prajna NV, Lalitha P, Dharmalingam K. Comparative proteomics of human male and female tears by two-dimensional electrophoresis. Exp Eye Res 2011;92:454-63.
62. Ng V, Cho P, Wong F, Chan Y. Variability of tear protein levels in normal young adults: diurnal (daytime) variation. Graefes Arch Clin Exp Ophthalmol 2001;239:257-63.
63. Wu K, Zhang Y. Clinical application of tear proteomics: present and future prospects. Proteomics Clin Appl 2007;1:972-82.
64. Müller AJ, Knuth M, Nikolaus KS, Krivánek R, Küster F, Hasslacher C. First clinical evaluation of a new percutaneous optical fiber glucose sensor for continuous glucose monitoring in diabetes. J Diabetes Sci Technol 2013;7:13-23.
65. Baca JT, Finegold DN, Asher SA. Tear glucose analysis for the noninvasive detection and monitoring of diabetes mellitus. Ocul Surf 2007;5:280-93.
66. Melki S, Todani A, Cherfan G. An implantable intraocular pressure transducer: initial safety outcomes. JAMA Ophthalmol 2014;132:1221-5.
67. Kaplan AV, Baim DS, Smith JJ, Feigal DA, Simons M, Jefferys D, Fogarty TJ, Kuntz RE, Leon MB. Medical device development: from prototype to regulatory approval. Circulation 2004;109:3068-72.
68. Maisel WH. Medical device regulation: an introduction for the practicing physician. Ann Intern Med 2004;140:296-302.
69. Kaufman N. Internet and information technology use in treatment of diabetes. Int J Clin Pract Suppl 2010;(166):41-6.
70. Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature 2004;429:464-8.